Metabolomic signatures in guinea pigs infected with epidemic-associated W-Beijing strains of mycobacterium tuberculosis

Journal of Proteome Research

Volumn 11, Issue 10, 2012, Pages 4873-4884

  Somashekar, Bagganahalli S ^a,b   Amin, Anita G ^a   Tripathi, Pratima ^b   Mackinnon, Neil ^b   Rithner, Christopher D ^a   Shanley, Crystal A ^a   Basaraba, Randall ^a   Henao Tamayo, Marcela ^a   Kato Maeda, Midori ^c   Ramamoorthy, Ayyalusamy ^b   Orme, Ian M ^a   Ordway, Diane J ^a   Chatterjee, Delphi ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

guinea pigs; metabolic profile; metabolomics; NMR; tuberculosis; W Beijing strains

Indexed keywords

ACETIC ACID; ADENOSINE PHOSPHATE; CHOLINE; CREATINE PHOSPHATE; ETHANOLAMINE; FORMIC ACID; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; LACTIC ACID; NICOTINAMIDE; OXYGEN RADICAL;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DISEASE COURSE; GUINEA PIG; METABOLITE; METABOLOMICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROMETER; TUBERCULOSIS;

ACETATES; ADENOSINE MONOPHOSPHATE; ANIMALS; CHOLINE; EPIDEMICS; ETHANOLAMINE; FORMATES; GLUTAMIC ACID; GLUTAMINE; GUINEA PIGS; HOST-PATHOGEN INTERACTIONS; LACTIC ACID; LUNG; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NIACINAMIDE; PHOSPHOCREATINE; PRINCIPAL COMPONENT ANALYSIS; ROC CURVE; TUBERCULOMA; TUBERCULOSIS, PULMONARY;

EID: 84867449305     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300345x     Document Type: Article

References (28)

1. Lienhardt, C.; Vernon, A.; Raviglione, M. C. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes Curr. Opin. Pulm. Med. 2010, 16 (3) 186-93
2. WHO. Anti-Tuberculosis Drug Resistance in the World, WHO/CDS/TB 2001.287; World Health Organization: Geneva, 2008.
3. Ginsberg, A. M.; Spigelman, M. Challenges in tuberculosis drug research and development Nat. Med. 2007, 13 (3) 290-4
4. Wallis, R. S.; Pai, M.; Menzies, D.; Doherty, T. M.; Walzl, G.; Perkins, M. D.; Zumla, A. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice Lancet 2010, 375 (9729) 1920-37
5. Walzl, G.; Ronacher, K.; Hanekom, W.; Scriba, T. J.; Zumla, A. Immunological biomarkers of tuberculosis Nat. Rev. Immunol. 2011, 11 (5) 343-54
6. Fletcher, H. A.; Owiafe, P.; Jeffries, D.; Hill, P.; Rook, G. A.; Zumla, A.; Doherty, T. M.; Brookes, R. H. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation Immunology 2004, 112 (4) 669-73
7. Waterman, D. S.; Bonner, F. W.; Lindon, J. C. Spectroscopic and statistical methods in metabonomics Bioanalysis 2009, 1 (9) 1559-78
8. Sansone, S. A.; Fan, T.; Goodacre, R.; Griffin, J. L.; Hardy, N. W.; Kaddurah-Daouk, R.; Kristal, B. S.; Lindon, J.; Mendes, P.; Morrison, N.; Nikolau, B.; Robertson, D.; Sumner, L. W.; Taylor, C.; van der Werf, M.; van Ommen, B.; Fiehn, O. The metabolomics standards initiative Nat. Biotechnol. 2007, 25 (8) 846-8
9. Lindon, J. C.; Holmes, E.; Nicholson, J. K. Metabonomics and its role in drug development and disease diagnosis Expert Rev. Mol. Diagn. 2004, 4 (2) 189-99
10. 1H magic angle spinning NMR studies J. Proteome Res. 2011, 10, 4186-95
11. Gagneux, S.; DeRiemer, K.; Van, T.; Kato-Maeda, M.; de Jong, B. C.; Narayanan, S.; Nicol, M.; Niemann, S.; Kremer, K.; Gutierrez, M. C.; Hilty, M.; Hopewell, P. C.; Small, P. M. Variable host-pathogen compatibility in Mycobacterium tuberculosis Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (8) 2869-73
12. Kato-Maeda, M.; Kim, E. Y.; Flores, L.; Jarlsberg, L. G.; Osmond, D.; Hopewell, P. C. Differences among sublineages of the East-Asian lineage of Mycobacterium tuberculosis in genotypic clustering Int. J. Tuberc. Lung Dis. 2010, 14 (5) 538-44
13. Kraft, S. L.; Dailey, D.; Kovach, M.; Stasiak, K. L.; Bennett, J.; McFarland, C. T.; McMurray, D. N.; Izzo, A. A.; Orme, I. M.; Basaraba, R. J. Magnetic resonance imaging of pulmonary lesions in guinea pigs infected with Mycobacterium tuberculosis Infect. Immun. 2004, 72 (10) 5963-71
14. Shang, S.; Harton, M.; Tamayo, M. H.; Shanley, C.; Palanisamy, G. S.; Caraway, M.; Chan, E. D.; Basaraba, R. J.; Orme, I. M.; Ordway, D. J. Increased Foxp3 expression in guinea pigs infected with W-Beijing strains of M. tuberculosis Tuberculosis 2011, 91 (5) 378-85
15. Turner, O. C.; Basaraba, R. J.; Orme, I. M. Immunopathogenesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis Infect. Immun. 2003, 71 (2) 864-71
16. Wong, J. W.; Cagney, G.; Cartwright, H. M. SpecAlign - processing and alignment of mass spectra datasets Bioinformatics 2005, 21 (9) 2088-90
17. Cattamanchi, A.; Hopewell, P. C.; Gonzalez, L. C.; Osmond, D. H.; Kawamura, L. M.; Daley, C. L.; Jasmer, R. M. A 13 year molecular epidemiological analysis of tuberculosis in San Francisco Int. J. Tuberc. Lung Dis. 2006, 10 (3) 297-304
18. Kato-Maeda, M.; Shanley, C. A.; Jarlsberg, L. G.; Shang, S.; Obregon-Henao, A.; Marisabel, H.; Basaraba, R. J.; Henao-Tamayo, M.; Cueto Barrozo, J.; Kawamura, M.; Hopewell, P. C.; Ordway, D. J.; Orme, I. M. East-Asian (Beijing) sublineages of Mycobacterium tuberculosis differ in virulence and pathogenicity in the guinea pig. Clin. Vaccine Immunol. 2012, in press.
19. Cui, Q.; Lewis, I. A.; Hegeman, A. D.; Anderson, M. E.; Li, J.; Schulte, C. F.; Westler, W. M.; Eghbalnia, H. R.; Sussman, M. R.; Markley, J. L. Metabolite identification via the Madison Metabolomics Consortium Database Nat. Biotechnol. 2008, 26 (2) 162-4
20. Ordway, D. J.; Shang, S.; Henao-Tamayo, M.; Obregon-Henao, A.; Nold, L.; Caraway, M.; Shanley, C. A.; Basaraba, R. J.; Duncan, C. G.; Orme, I. M. Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells Clin. Vaccine Immunol. 2011, 18 (9) 1527-35
21. Palanisamy, G. S.; DuTeau, N.; Eisenach, K. D.; Cave, D. M.; Theus, S. A.; Kreiswirth, B. N.; Basaraba, R. J.; Orme, I. M. Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs Tuberculosis 2009, 89 (3) 203-9
22. Ordway, D.; Henao-Tamayo, M.; Harton, M.; Palanisamy, G.; Troudt, J.; Shanley, C.; Basaraba, R. J.; Orme, I. M. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation J. Immunol. 2007, 179 (1) 522-31
23. Via, L. E.; Lin, P. L.; Ray, S. M.; Carrillo, J.; Allen, S. S.; Eum, S. Y.; Taylor, K.; Klein, E.; Manjunatha, U.; Gonzales, J.; Lee, E. G.; Park, S. K.; Raleigh, J. A.; Cho, S. N.; McMurray, D. N.; Flynn, J. L.; Barry, C. E., III. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates Infect. Immun. 2008, 76 (6) 2333-40
24. Lenaerts, A. J.; Hoff, D.; Aly, S.; Ehlers, S.; Andries, K.; Cantarero, L.; Orme, I. M.; Basaraba, R. J. Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910 Antimicrob. Agents Chemother. 2007, 51 (9) 3338-45
25. Dakubo, G. D. The Warburg phenomenon and other metabolic alterations of cancer cells. In Mitochondrial Genetics and Cancer; Springer: Heidelberg, 2010; pp 39-66.
26. Vazquez, A.; Liu, J. X.; Zhou, Y.; Oltvai, Z. N. Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited BMC Syst. Biol. 2010, 4, 58-60
27. Langlois, R. A.; Legge, K. L. Respiratory dendritic cells: mediators of tolerance and immunity Immunol. Res. 2007, 39 (1-3) 128-45
28. Venketaraman, V.; Dayaram, Y. K.; Talaue, M. T.; Connell, N. D. Glutathione and nitrosoglutathione in macrophage defense against Mycobacterium tuberculosis Infect. Immun. 2005, 73 (3) 1886-9